Intraperitoneal chemotherapy for gastric cancer with peritoneal disease: experience from Singapore and Japan

Phase I study of weekly intraperitoneal paclitaxel combined with S-1 and oxaliplatin for gastric cancer with peritoneal metastasis.

(2017) Hironori Ishigami et al.   JOURNAL OF CLINICAL ONCOLOGY

Computed tomography of the thorax for gastric cancer staging: is it necessary?

(2015) C. S. Chong et al.   Scandinavian Journal of Surgery

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Salvage Gastrectomy After Intravenous and Intraperitoneal Paclitaxel (PTX) Administration with Oral S-1 for Peritoneal Dissemination of Advanced Gastric Cancer with Malignant Ascites

(2013) Joji Kitayama et al.   ANNALS OF SURGICAL ONCOLOGY

A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis

(2013) Hironori Yamaguchi et al.   CANCER

Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis

(2013) S. Fushida et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

A randomized phase II trial of S-1-oxaliplatin versus capecitabine–oxaliplatin in advanced gastric cancer

(2012) Gun Min Kim et al.   EUROPEAN JOURNAL OF CANCER

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial

(2011) Xiao-Jun Yang et al.   ANNALS OF SURGICAL ONCOLOGY

Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

(2011) Atsushi Ohtsu et al.   JOURNAL OF CLINICAL ONCOLOGY

Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination

(2011) Yoshiyuki Fujiwara et al.   JOURNAL OF SURGICAL ONCOLOGY

Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: A systematic review of survival, mortality, and morbidity

(2011) Richdeep S. Gill et al.   JOURNAL OF SURGICAL ONCOLOGY

Phase I Study of Biweekly Intravenous Paclitaxel plus Intraperitoneal Cisplatin and Paclitaxel for Gastric Cancer with Peritoneal Metastasis

(2011) Hironori Ishigami et al.   ONCOLOGY

Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy

(2010) Olivier Glehen et al.   ANNALS OF SURGICAL ONCOLOGY

Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis

(2009) H. Ishigami et al.   ANNALS OF ONCOLOGY

Extensive Intraoperative Peritoneal Lavage as a Standard Prophylactic Strategy for Peritoneal Recurrence in Patients with Gastric Carcinoma

(2009) Masafumi Kuramoto et al.   ANNALS OF SURGERY

Chemotherapy for metastatic disease: review from JCOG trials

(2008) Narikazu Boku   International Journal of Clinical Oncology

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

(2008) Wasaburo Koizumi et al.   LANCET ONCOLOGY

Phase II Study of a Combination of S-1 and Paclitaxel in Patients with Unresectable or Metastatic Gastric Cancer

(2008) Hiroyuki Narahara et al.   ONCOLOGY